# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
-- Company advances monetization of wheat technology with one-time payment of $4 million --Arcadia Biosciences, Inc.® (NASDAQ:R...
Deutsche Bank analyst David Begleiter maintains Corteva (NYSE:CTVA) with a Buy and raises the price target from $62 to $65.
RBC Capital analyst Arun Viswanathan maintains Corteva (NYSE:CTVA) with a Outperform and raises the price target from $62 to...
Canaccord Genuity analyst Bobby Burleson maintains Corteva (NYSE:CTVA) with a Buy and raises the price target from $60 to $65.
Wells Fargo analyst Richard Garchitorena maintains Corteva (NYSE:CTVA) with a Overweight and raises the price target from $6...
BMO Capital analyst Joel Jackson maintains Corteva (NYSE:CTVA) with a Outperform and raises the price target from $64 to $67.
Oppenheimer analyst Kristen Owen maintains Corteva (NYSE:CTVA) with a Outperform and raises the price target from $67 to $69.
Mizuho analyst Edlain Rodriguez maintains Corteva (NYSE:CTVA) with a Buy and raises the price target from $56 to $61.